• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞心肌成形术:一种用于心肌再生的新治疗方法。

Cellular cardiomyoplasty: a new therapeutic approach for regenerating the myocardium.

作者信息

Piano Mariann R, Carrigan Timothy M

机构信息

Medical-Surgical Nursing, University of Illinois at Chicago, College of Nursing, Chicago, Ill 60612, USA.

出版信息

J Cardiovasc Nurs. 2003 Nov-Dec;18(5):374-81. doi: 10.1097/00005082-200311000-00009.

DOI:10.1097/00005082-200311000-00009
PMID:14680341
Abstract

One of the most promising new therapeutic techniques for the augmentation and regeneration of the myocardium is cellular cardiomyoplasty. Reports from animal and clinical investigations indicate that the transplant of different cell types, such as autologous skeletal myoblasts and adult stem cells, into injured myocardium results in the generation of new cardiac myocytes and improvement in myocardial performance. Although there is no consensus with regard to the best cell type to transplant or the extent of myocardial renewal and regeneration, the technique of cardiac cellular myoplasty may become one of the most important advancements in the treatment of cardiovascular diseases such as myocardial infarction and heart failure.

摘要

心肌增强与再生最有前景的新治疗技术之一是细胞心肌成形术。动物和临床研究报告表明,将不同类型的细胞,如自体骨骼肌成肌细胞和成人干细胞,移植到受损心肌中可导致新心肌细胞的生成并改善心肌功能。尽管对于最佳移植细胞类型或心肌更新与再生的程度尚无共识,但细胞心肌成形术可能成为治疗心肌梗死和心力衰竭等心血管疾病最重要的进展之一。

相似文献

1
Cellular cardiomyoplasty: a new therapeutic approach for regenerating the myocardium.细胞心肌成形术:一种用于心肌再生的新治疗方法。
J Cardiovasc Nurs. 2003 Nov-Dec;18(5):374-81. doi: 10.1097/00005082-200311000-00009.
2
Cellular cardiomyoplasty: clinical application.细胞心肌成形术:临床应用
Ann Thorac Surg. 2004 Mar;77(3):1121-30. doi: 10.1016/j.athoracsur.2003.09.081.
3
Endogenous cardiac stem cells.内源性心脏干细胞
Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):31-48. doi: 10.1016/j.pcad.2007.03.005.
4
Cellular cardiomyoplasty and cardiac tissue engineering for myocardial therapy.细胞心肌成形术和心脏组织工程学用于心肌治疗。
Adv Drug Deliv Rev. 2010 Jun 15;62(7-8):784-97. doi: 10.1016/j.addr.2010.03.001. Epub 2010 Mar 6.
5
Stem cell experiments and initial clinical trial of cellular cardiomyoplasty.干细胞实验与细胞心肌成形术的初步临床试验。
Asian Cardiovasc Thorac Ann. 2009 Dec;17(6):581-6. doi: 10.1177/0218492309349363.
6
Myocardial tissue engineering and regeneration as a therapeutic alternative to transplantation.心肌组织工程与再生作为移植的一种治疗替代方案。
Curr Top Microbiol Immunol. 2004;280:139-64. doi: 10.1007/978-3-642-18846-6_4.
7
Cellular cardiomyoplasty--cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure?细胞心肌成形术——心肌细胞、骨骼肌成肌细胞还是干细胞用于心肌再生和心力衰竭治疗?
Cardiovasc Res. 2003 May 1;58(2):358-68. doi: 10.1016/s0008-6363(02)00739-3.
8
Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts.
Cell Transplant. 2000 May-Jun;9(3):359-68. doi: 10.1177/096368970000900307.
9
Cell sources for cardiac regeneration--which cells and why.用于心脏再生的细胞来源——哪些细胞以及为何选择这些细胞。
Am Heart Hosp J. 2006 Spring;4(2):95-7. doi: 10.1111/j.1541-9215.2006.04651.x.
10
Recent advancements in tissue engineering for stem cell-based cardiac therapies.基于干细胞的心脏治疗的组织工程学最新进展。
Ther Deliv. 2013 Apr;4(4):503-16. doi: 10.4155/tde.13.13.

引用本文的文献

1
Effects of bone marrow cell transplant on thyroid function in an I131-induced low T4 and elevated TSH rat model.骨髓细胞移植对I131诱导的低T4和高TSH大鼠模型甲状腺功能的影响。
J Negat Results Biomed. 2007 Jan 18;6:1. doi: 10.1186/1477-5751-6-1.